Protein microarrays guide, tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

Nature Biotechnology

Volumn 21, Issue 9, 2003, Pages 1033-1039

  Robinson, William H ^a,b,c   Fontoura, Paulo ^a   Lee, Byung J ^a   De Vegvar, Henry E Neuman ^a,b   Tom, Jennifer ^a   Pedotti, Rosetta ^a   DiGennaro, Carla D ^a   Mitchell, Dennis J ^a   Fong, Derek ^a   Ho, Peggy P K ^a   Ruiz, Pedro J ^a   Maverakis, Emanual ^d   Stevens, David B ^e   Bernard, Claude C A ^k   Martin, Roland ^f   Kuchroo, Vijay K ^d   Van Noort, Johannes M ^g   Genain, Claude P ^h   Amor, Sandra ⁱ   Olsson, Tomas ^j   Utz, Paul J ^a,c   Garren, Hideki ^c   Steinman, Lawrence ^a,c   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Bayhill Therapeutics   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e PORTLAND VA MEDICAL CENTER   (United States)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g TNO   (Netherlands)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEINS; VACCINES;

AUTOIMMUNE RESPONSE;

BIOTECHNOLOGY;

AUTOANTIBODY; AUTOANTIGEN; COMPLEMENTARY DNA; DNA VACCINE; EPITOPE; INTERLEUKIN 4; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN[139-151]; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY RESPONSE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; DRUG EFFICACY; GENETIC CODE; HELPER CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN TARGETING; PROTEOMICS; REVIEW;

ANIMALS; DRUG TOLERANCE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOASSAY; MICE; MULTIPLE SCLEROSIS; MYELIN SHEATH; PROTEIN ARRAY ANALYSIS; PROTEIN INTERACTION MAPPING; TREATMENT OUTCOME; VACCINES, DNA;

EID: 10744231057     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt859     Document Type: Review

References (41)

1. Milich, D.R., McLachlan, A., Thornton, G.B. & Hughes, J.L. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T-cell site. Nature 329, 547-549 (1987).
2. Lehmann, P.V., Forsthuber, T., Miller, A. & Sercarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155-157 (1992).
3. Yu, M., Johnson, J.M. & Tuohy, V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183, 1777-1788 (1996).
4. James, J.A., Gross, T., Scofield, R.H. & Harley, J.B. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PGMRPP and PGIRGP induce spliceosome autoimmunity. J. Exp. Med. 181, 453-461 (1995).
5. Tisch, R. & McDevitt, H. Insulin-dependent diabetes mellitus. Cell 85, 291-297 (1996).
6. McRae, B.L., Vanderlugt, C.L., Dal Canto, M.C. & Miller, S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182, 75-85 (1995).
7. Genain, C., Cannella, B., Hauser, S. & Raine, C. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5, 170-175 (1999).
8. Genain, C.P. et al. Late complications of immune deviation therapy in a nonhuman primate. Science 274, 2054-2057 (1996).
9. Steinman, L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299-302 (1996).
10. Garren, H. et al. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity 15, 15-22 (2001).
11. Wekerle, H. Remembering MOG: autoantibody-mediated demyelination in multiple sclerosis? Nat. Med. 5, 153-154 (1999).
12. Robinson, H.L., Hunt, L.A. & Webster, R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11, 957-960 (1993).
13. Ulmer, J.B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749 (1993).
14. Ruiz, P. et al. Suppressive immunization with DNA encoding a self-protein prevents autoimmune disease: modulation of T cell costimulation. J. Immunol. 162, 3336-3341 (1999).
15. Ramshaw, I.A. et al. DNA vaccines for the treatment of autoimmune disease. Immunol. Cell Biol. 75, 409-413 (1997).
16. Urbanek-Ruiz, I. et al. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice. Clin. Immunol. 100, 164-171 (2001).
17. Balasa, B. et al. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection. Clin. Immunol 99, 241-252 (2001).
18. Bot, A. et al. Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 2950-2955 (2001).
19. Robinson, W.H. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8, 295-301 (2002).
20. Zamvil, S. et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317, 355-358 (1985).
21. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
22. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).
23. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. & Weinshenker, B.G. Multiple sclerosis. N. Engl. J. Med. 343, 938-952 (2000).
24. Morris-Downes, M.M. et al. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 122, 20-33 (2002).
25. Shlomchik, M.J., Craft, J.E. & Mamula, M.J. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1, 147-153 (2001).
26. Goverman, J. et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72, 551-560 (1993).
27. Fazekas de St, G. & Webster, R.G. Disquisitions of original antigenic sin. I. Evidence in man. J. Exp. Med. 124, 331-345 (1966).
28. Klenerman, P. & Zinkernagel, R.M. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394, 482-485 (1998).
29. Tuohy, V.K., Yu, M., Yin, L., Kawczak, J.A. & Kinkel, R.P. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189, 1033-1042 (1999).
30. Steinman, L. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy. J. Exp. Med. 189, 1021-1024 (1999).
31. Critchfield, J.M. et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263, 1139-1143 (1994).
32. Brocke, S. et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343-346 (1996).
33. Boon, L. et al. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J. Immunol. 167, 2942-2949 (2001).
34. Miller, S.D. et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3, 739-745 (1995).
35. Tisch, R. et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366, 72 (1993).
36. Yu, L. et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. USA 97, 1701-1706 (2000).
37. Robinson, W.H., Garren, H., Utz, P.J. & Steinman, L. Millennium Award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease. Clin. Immunol. 103, 7-12 (2002).
38. Warren, K., Katz, I. & Steinman, L. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B cell epitope and a model of its unique features. Proc. Natl. Acad. Sci. USA 92, 11061-11065 (1995).
39. Haab, B.B., Dunham, M.J. & Brown, P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2, research0004.0001-0004.0013 (2001).
40. Pedotti, R. et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2, 216-222 (2001).
41. Storey, J.D. A direct approach to false discovery rates. J.R. Stat. Soc. Ser. B-Stat. Methodol. 64, 479-498 (2002).